Describe the Progression of Inflammatory Orbitopathy and the Biological Progression of Patients Receiving Second-line Treatment

Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

NCT05329090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis

NCT00646425 ·Status: TERMINATED ·Phase: PHASE2

Genetics and Epigenetics of Graves' Orbitopathy

NCT04488406 ·Status: COMPLETED

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

NCT00307671 ·Status: COMPLETED ·Phase: PHASE4

Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein

NCT03345537 ·Status: COMPLETED

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

NCT05162066 ·Status: TERMINATED ·Phase: PHASE2

Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy

NCT05782933 ·Status: UNKNOWN ·Phase: NA

B Cells in Idiopathic Nephrotic Syndrome

NCT05712369 ·Status: COMPLETED ·Phase: NA

Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis

NCT02556866 ·Status: TERMINATED ·Phase: PHASE2

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

NCT05755386 ·Status: RECRUITING ·Phase: PHASE3

Pharmacokinetics Study of Mycophenolic Acid in Patients With an Autoimmune Bullous Dermatose, Pemphigus or Cicatricial Pemphigoid.

NCT02993133 ·Status: COMPLETED ·Phase: PHASE3

Study of Clinical, Biological Characteristics and Quality of Life of Patients With Hereditary or Acquired Non Drug-induced Bradykinin-mediated Angioedema, Monitored in Besançon's Partner Site Reference Center for Studies of Kinin-mediated Angioedema (CREAK)

NCT03240991 ·Status: COMPLETED

Diagnosis of MGRS in Patients With Paraproteinemias: Clinical, Anatomopathological and Pathophysiological Study

NCT03629561 ·Status: UNKNOWN

Cortico-saving Treatments Proposed for CLIPPERS: a First Cohort

NCT01740180 ·Status: TERMINATED

A Study on the Efficacy and Safety of Telitacicept in the Treatment of Children Ocular Myasthenia Gravis

NCT07298928 ·Status: NOT_YET_RECRUITING ·Phase: NA

Bosentan in the Treatment of Giant Cell Arteritis

NCT06957002 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases

NCT02280902 ·Status: COMPLETED

Screening for Prognostic Biomarkers of Severe Bell's Palsy in Adults

NCT05582915 ·Status: RECRUITING

Obinutuzumab for Remission Induction in Patients With Relapsing PR3-ANCA Granulomatosis With Polyangiitis

NCT06940661 ·Status: RECRUITING ·Phase: PHASE2

A Controlled Study of Steroids Plus Cyclosporin Therapy for Patients of Idiopathic Membranous Nephropathy

NCT02173106 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Tolerance of the Association of ANIFROLUMAB (300mg) IV Every Four Weeks and Phototherapy Versus Phototherapy in Adults With Progressive Vitiligo

NCT05917561 ·Status: RECRUITING ·Phase: PHASE2

Steroids Pharmacokinetics and the Response to Prednisone Therapy in Giant Cell Arteritis

NCT01400464 ·Status: UNKNOWN ·Phase: PHASE4

Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy

NCT05894512 ·Status: COMPLETED

Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis

NCT00059748 ·Status: RECRUITING

The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease

NCT01306955 ·Status: UNKNOWN ·Phase: PHASE4